# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA1799105 | F | Selectivity index, ratio of CC50 for human MT4 cells to IC50 for HIV1 3B | 11 | cell-based format | Scientific Literature | |||
2. | ALA1799106 | F | Selectivity index, ratio of CC50 for human MT4 cells to IC50 for HIV2 ROD | 11 | cell-based format | Scientific Literature | |||
3. | ALA1799107 | F | Antiviral activity against Coxsackie virus B1 up to 100 ug/mL | Coxsackievirus B1 | 9 | organism-based format | Scientific Literature | ||
4. | ALA1799108 | F | Antiviral activity against Coxsackie virus B3 up to 100 ug/mL | Coxsackievirus B3 | 9 | organism-based format | Scientific Literature | ||
5. | ALA1799109 | F | Antiviral activity against Human poliovirus 3 up to 100 ug/mL | Poliovirus 3 | 9 | organism-based format | Scientific Literature | ||
6. | ALA1798703 | T | Toxicity against human MT4 cells by MTT assay | Homo sapiens | 11 | cell-based format | Scientific Literature | ||
7. | ALA1798704 | F | Antiviral activity against HIV1 3B infected in human MT4 cells coinjected with HTLV1 assessed as reduction in virus induced cytopathicity measured 5 days post infection by MTT assay | Human immunodeficiency virus 1 | 11 | organism-based format | Scientific Literature | ||
8. | ALA1798705 | F | Antiviral activity against HIV2 ROD infected in human MT4 cells assessed as reduction in virus induced cytopathicity measured 5 days post infection by MTT assay | Human immunodeficiency virus 2 | 11 | organism-based format | Scientific Literature |